ImmunityBio, Inc.

NASDAQ:IBRX

2.87 (USD) • At close March 14, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

202420232022202120202019201820172016201520142013
Omzet 14.7450.6220.240.9340.6052.2020.0470.0450.0440.2360.6410.6
Kosten van de omzet 0024.19209.1479.012-3.1100000.253
Brutowinst 14.7450.622-23.9520.934-8.542-6.813.1570.0450.0440.2360.6410.347
Brutowinstmarge 11-99.81-14.119-3.09367.1711110.578
Onderzoek- en ontwikkelingskosten 190.144232.366248.149195.958139.507111.99753.41839.77826.54611.4341.5950.446
Algemene en administratieve kosten 00000028.39457.12195.391227.6784.3260
Verkoop- en marketingkosten 0000007.069-3.3-1-1.47200
Verkoop-, algemene en administratieve kosten 168.783129.62102.708135.25671.31846.45635.46353.82194.391226.2064.3262.419
Overige kosten 00.886-0.7360.1931.486-0.534000000
Bedrijfskosten 358.927362.872350.857331.214210.825158.45388.88193.599120.937237.645.9212.865
Bedrijfsresultaat -344.182-362.25-351.298-330.28-220.88-156.251-98.389-99.12-124.5-238.876-6.212-2.269
Bedrijfsresultaat ratio -23.342-582.395-1,463.742-353.619-365.091-70.959-2,093.383-2,202.667-2,829.545-1,012.186-9.691-3.782
Totaal overige inkomsten en kosten netto -69.382-221.642-65.988-19.559-25.36-3.9471.662.2043.1191.699-0.6090.223
Inkomen voor belasting -413.564-583.892-417.286-349.839-226.033-160.263-96.729-96.916-121.381-237.177-6.212-2.046
Inkomen voor belasting ratio -28.048-938.733-1,738.692-374.56-373.608-72.781-2,058.064-2,153.689-2,758.659-1,004.987-9.691-3.41
Belastingkosten 0-0.040.0340.009-1.846-0.105-0.503-0.493-0.572-0.3010.0010.001
Nettowinst -413.564-583.196-417.32-349.848-224.187-160.158-96.226-96.423-120.809-236.876-6.213-2.047
Nettowinstmarge -28.048-937.614-1,738.833-374.57-370.557-72.733-2,047.362-2,142.733-2,745.659-1,003.712-9.693-3.412
WPA (Winst Per Aandeel) -0.59-1.15-1.04-0.9-0.59-0.42-1.22-1.2-1.47-3.31-0.02-2.57
Verwaterde WPA -0.59-1.15-1.04-0.9-0.59-0.42-1.22-1.2-1.47-3.31-0.02-2.57
EBITDA -264.433-436.182-335.511-315.38-187.934-142.274-86.741-90.732-117.708-235.705-5.677-1.579
EBITDA ratio -17.934-701.257-1,433.242-338.655-322.526-63.568-1,890.085-2,078.978-2,747.568-1,005.949-9.491-2.632